HomeCompareSMMNY vs DIVO

SMMNY vs DIVO: Dividend Comparison 2026

SMMNY yields 1.74% · DIVO yields 6.49%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 DIVO wins by $5.9K in total portfolio value
10 years
SMMNY
SMMNY
● Live price
1.74%
Share price
$21.10
Annual div
$0.37
5Y div CAGR
12.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.8K
Annual income
$704.62
Full SMMNY calculator →
DIVO
DIVO
● Live price
6.49%
Share price
$44.85
Annual div
$2.91
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$30.7K
Annual income
$981.68
Full DIVO calculator →

Portfolio growth — SMMNY vs DIVO

📍 DIVO pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSMMNYDIVO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SMMNY + DIVO cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SMMNY pays
DIVO pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SMMNY
Annual income on $10K today (after 15% tax)
$147.96/yr
After 10yr DRIP, annual income (after tax)
$598.93/yr
DIVO
Annual income on $10K today (after 15% tax)
$552.00/yr
After 10yr DRIP, annual income (after tax)
$834.43/yr
At 15% tax rate, DIVO beats the other by $235.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SMMNY + DIVO for your $10,000?

SMMNY: 50%DIVO: 50%
100% DIVO50/50100% SMMNY
Portfolio after 10yr
$27.8K
Annual income
$843.15/yr
Blended yield
3.04%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SMMNY right now

SMMNY
Analyst Ratings
1
Buy
1
Hold
Consensus: Buy
Altman Z
2.8
Piotroski
6/9
DIVO
No analyst data
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SMMNY buys
0
DIVO buys
0
No recent congressional trades found for SMMNY or DIVO in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSMMNYDIVO
Forward yield1.74%6.49%
Annual dividend / share$0.37$2.91
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR12.7%0%
Portfolio after 10y$24.8K$30.7K
Annual income after 10y$704.62$981.68
Total dividends collected$4.0K$8.2K
Payment frequencyquarterlyquarterly
SectorStockETF

Year-by-year: SMMNY vs DIVO ($10,000, DRIP)

YearSMMNY PortfolioSMMNY Income/yrDIVO PortfolioDIVO Income/yrGap
1← crossover$10,896$196.18$11,349$649.42$453.00DIVO
2$11,884$225.15$12,833$688.83$949.00DIVO
3$12,975$258.65$14,459$727.90$1.5KDIVO
4$14,180$297.42$16,238$766.49$2.1KDIVO
5$15,515$342.38$18,179$804.47$2.7KDIVO
6$16,996$394.57$20,293$841.71$3.3KDIVO
7$18,641$455.25$22,591$878.14$4.0KDIVO
8$20,472$525.91$25,087$913.65$4.6KDIVO
9$22,513$608.32$27,791$948.18$5.3KDIVO
10$24,793$704.62$30,718$981.68$5.9KDIVO

SMMNY vs DIVO: Complete Analysis 2026

SMMNYStock

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. The company operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. The Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory, molecular and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, and solutions and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services and consulting capabilities, and digital solutions and applications for managing treatment and therapy. The Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms, including a robotic-assisted platform for endovascular coronary and peripheral vascular interventions. It also provides equipment performance management, clinical education and e-learning, asset management, and managed departmental services for laboratories and healthcare facilities, as well as consulting and digital health services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Full SMMNY Calculator →

DIVOETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →
📬

Get this SMMNY vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SMMNY vs SCHDSMMNY vs JEPISMMNY vs OSMMNY vs KOSMMNY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.